Patheon announces date of fiscal 2012 first quarter financial results

TORONTO, Feb. 22, 2012 /PRNewswire/ -Patheon Inc. (TSX: PTI), a leading provider of contract development and
manufacturing services to the global pharmaceutical industry, announced
today that it will report its fiscal 2012 first quarter financial
results on Friday, March 9, 2012.

In conjunction with its financial results announcement, Patheon will
host a conference call and Web cast on Friday, March 9, 2012 at 10:00
a.m. (EST). The financial results news release will be issued at
approximately 7:30 a.m. (EST) on Friday, March 9, 2012.

Interested parties are invited to access the conference call, via
telephone, toll free at 1-888-231-8191 (U.S., including Puerto Rico)
and 1-647-427-7452 (Canada and International). To view the slides
accompanying the conference call click here. The link to the Web cast will also be posted on the investor relations
section of Patheon's Web site prior to the call. Participants are
encouraged to dial in five to fifteen minutes in advance to avoid
delays. A live audio will also be available via the web at http://ir.patheon.com/events.cfm. (Please note that either Windows Media Player or RealPlayer are
required).

A telephone replay of the conference call will be available between
Friday, March 9, 2012 and Friday, March 16, 2012 by dialling
1-855-859-2056(toll free) or 1-403-451-9481, and by entering identification number
55107868, followed by the number key. The conference call will also be
archived at http://ir.patheon.com/events.cfm.

ABOUT PATHEON
Patheon Inc. (TSX: PTI) is a leading global provider of contract
development and manufacturing services to the global pharmaceutical
industry. The company provides the highest quality products and
services to approximately 300 of the world's leading pharmaceutical and
biotechnology companies. Its services range from preclinical
development through commercial manufacturing of a full array of dosage
forms including parenteral, soft gel, solid and liquid forms.

The company's comprehensive range of fully integrated Pharmaceutical
Development Services includes pre-formulation, formulation, analytical
development, clinical manufacturing, scale-up and
commercialization. The company's integrated development and
manufacturing network of 10 manufacturing facilities, nine development
centers and one clinical trial material packaging facility across North
America and Europe, enables customer products to be launched with
confidence anywhere in the world.